Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-16

Clinical Trial Update: Evaluation of Memantine Versus Placebo on Ischemic Stroke Outcome [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating memantine versus placebo for outcomes after ischemic stroke has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Memantine (memantine)

Snippet

Sponsor: Mazandaran University of Medical Sciences | Conditions: Ischemic Stroke, Excitotoxicity | Phase 3 | Status: COMPLETED | Results posted: 2020-09-16